The Emergence of Pharmacy Fraud
in Co-Pay Programs
Joann Whitcher, A MM&M Digital Publication
Featuring Tim Ogren, Senior Vice President, Products
Fraud involving pharmaceutical manufacturers’ patient co-pay and voucher programs is on the rise. The increase in the number of co-pay and voucher programs, combined with the increasingly generous benefits provided by pharmaceutical manufacturers, has created a veritable breeding ground for fraudulent pharmacy activity. TrialCard and its team of experts has developed an enhanced monitoring service to protect its clients and their valuable reimbursement budgets.